We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System (CAuSMIc II)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00626314
Recruitment Status : Unknown
Verified February 2008 by Mytogen, Inc..
Recruitment status was:  Not yet recruiting
First Posted : February 29, 2008
Last Update Posted : February 29, 2008
Sponsor:
Information provided by:
Mytogen, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2010
  Estimated Study Completion Date : August 2010